• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Worldwide vaccine inequality threatens to unleash the next COVID-19 variant.全球疫苗不平等有可能引发下一个 COVID-19 变体。
Int J Infect Dis. 2022 Oct;123:133-135. doi: 10.1016/j.ijid.2022.08.010. Epub 2022 Aug 18.
2
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.2、3 和 4 剂 COVID-19 mRNA 疫苗在 SARS-CoV-2 奥密克戎 BA.1 和 BA.2/BA.2.12.1 亚谱系占主导地位期间对免疫功能正常成年人的有效性 - VISION 网络,10 个州,2021 年 12 月至 2022 年 6 月。
MMWR Morb Mortal Wkly Rep. 2022 Jul 22;71(29):931-939. doi: 10.15585/mmwr.mm7129e1.
3
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间,mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络,10 个州,2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
4
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.奥密克戎变异株广泛传播期间,养老院居民接种 COVID-19 追加初级或加强疫苗剂量对预防 SARS-CoV-2 感染的效果-美国,2022 年 2 月 14 日-3 月 27 日。
MMWR Morb Mortal Wkly Rep. 2022 May 6;71(18):633-637. doi: 10.15585/mmwr.mm7118a4.
5
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.奥密克戎变异株疫苗有效性的系统评价和荟萃分析。
Front Public Health. 2022 Jul 13;10:940956. doi: 10.3389/fpubh.2022.940956. eCollection 2022.
6
Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.南非出现的 SARS-CoV-2 变异株奥密克戎的序列分析。
J Med Virol. 2022 Apr;94(4):1728-1733. doi: 10.1002/jmv.27516. Epub 2021 Dec 27.
7
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.COVID-19 mRNA 疫苗在奥密克戎为主导期间对免疫功能低下成年人 COVID-19 相关住院的有效性- VISION 网络,10 个州,2021 年 12 月至 2022 年 8 月。
MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1335-1342. doi: 10.15585/mmwr.mm7142a4.
8
Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant.关于奥密克戎(B.1.1.529)SARS-CoV-2 变体的新证据。
J Med Virol. 2022 May;94(5):1876-1885. doi: 10.1002/jmv.27626. Epub 2022 Feb 3.
9
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
10
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.二价 mRNA 疫苗预防有症状的 SARS-CoV-2 感染的效果-增加社区获得检测的项目,美国,2022 年 9 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Dec 2;71(48):1526-1530. doi: 10.15585/mmwr.mm7148e1.

引用本文的文献

1
Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword.大流行悖论:新冠疫情危机如何将疫苗犹豫变成一把双刃剑。
Hum Vaccin Immunother. 2025 Dec;21(1):2543167. doi: 10.1080/21645515.2025.2543167. Epub 2025 Aug 12.
2
Strengthening global health Equity: The imperative of the WHO pandemic agreement.加强全球卫生公平:世界卫生组织大流行协议的必要性。
New Microbes New Infect. 2025 Jun 13;66:101607. doi: 10.1016/j.nmni.2025.101607. eCollection 2025 Aug.
3
Last-mile delivery increases vaccine uptake in Sierra Leone.最后一英里投递提高了塞拉利昂的疫苗接种率。
Nature. 2024 Mar;627(8004):612-619. doi: 10.1038/s41586-024-07158-w. Epub 2024 Mar 13.
4
Vaccine inequity: a threat to Africa's recovery from COVID-19.疫苗不平等:对非洲从新冠疫情中复苏的威胁。
Trop Med Health. 2023 Dec 19;51(1):69. doi: 10.1186/s41182-023-00564-2.
5
Areas of Concern and Support among the Austrian General Population: A Qualitative Content Analytic Mapping of the Shift between Winter 2020/21 and Spring 2022.奥地利普通民众关注和支持的领域:对2020/21年冬季至2022年春季期间转变的定性内容分析映射
Healthcare (Basel). 2023 Sep 14;11(18):2539. doi: 10.3390/healthcare11182539.
6
What have we learnt from Covid-19 Pandemia? Looking to the future.我们从新冠大流行中学到了什么?展望未来。
Pulmonology. 2023 Mar-Apr;29(2):108-110. doi: 10.1016/j.pulmoe.2022.08.006. Epub 2022 Sep 9.

本文引用的文献

1
As COVID-19 vaccines arrive in Africa, Omicron is reducing supply and increasing demand.随着新冠疫苗抵达非洲,奥密克戎毒株却在减少供应并增加需求。
Nat Med. 2021 Dec 13. doi: 10.1038/d41591-021-00073-x.
2
Conquering COVID: How Global Vaccine Inequality Risks Prolonging the Pandemic.战胜新冠疫情:全球疫苗不平等如何延长疫情大流行风险
Open Forum Infect Dis. 2021 Sep 9;8(10):ofab443. doi: 10.1093/ofid/ofab443. eCollection 2021 Oct.
3
Social media, vaccine hesitancy and trust deficit in immunization programs: a qualitative enquiry in Malappuram District of Kerala, India.社交媒体、疫苗犹豫和免疫项目中的信任缺失:印度喀拉拉邦马拉普兰地区的定性研究
Health Res Policy Syst. 2021 Aug 11;19(Suppl 2):56. doi: 10.1186/s12961-021-00698-x.

全球疫苗不平等有可能引发下一个 COVID-19 变体。

Worldwide vaccine inequality threatens to unleash the next COVID-19 variant.

机构信息

James A Haley Veterans Hospital, Division of Infectious Diseases and International Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.

出版信息

Int J Infect Dis. 2022 Oct;123:133-135. doi: 10.1016/j.ijid.2022.08.010. Epub 2022 Aug 18.

DOI:10.1016/j.ijid.2022.08.010
PMID:35988865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9385581/
Abstract

The emergence of the Omicron variant (B.1.1.529 BA.1) near Johannesburg heralded the development of an unprecedented number of new COVID-19 infections across South Africa in November 2021. Omicron and its subvariants would soon become the dominant strains across Africa, Europe, and the United States. As with the Delta variant (B.1.617.2), Omicron emerged from an industrialized nation with one of the lowest vaccination rates of any well-developed country. The emergence of variants from undervaccinated regions is a direct consequence of the virus replicating unchecked through an unprotected population. Despite this, the United States and other higher-income nations have adopted a strategy of preferentially inoculating their citizens with multiple and booster doses, whereas lower-income nations struggle with vaccine availability, infrastructure, and their own vaccine manufacturing capability. Much more needs to be done to address worldwide vaccine inequities and prevent the emergence of the next devastating variant. The persistence of the pandemic anywhere remains an ongoing threat to citizens everywhere.

摘要

奥密克戎变异株(B.1.1.529 BA.1)在约翰内斯堡附近出现,预示着 2021 年 11 月南非 COVID-19 感染病例数量将前所未有地增加。奥密克戎及其亚变种将很快成为非洲、欧洲和美国的主要流行株。与德尔塔变异株(B.1.617.2)一样,奥密克戎也是从一个工业化国家出现的,其疫苗接种率是所有发达国家中最低的之一。未接种疫苗地区出现变异株,是病毒在未受保护人群中不受控制地复制的直接后果。尽管如此,美国和其他高收入国家已经采取了优先为其公民接种多种疫苗和加强针的策略,而低收入国家则在疫苗供应、基础设施和自身疫苗制造能力方面存在困难。为了解决全球疫苗不平等问题,防止下一个破坏性变异株的出现,还需要做更多的工作。任何地方的大流行持续存在,仍然是各地公民面临的持续威胁。